Skip to content
DraconiticResearch
Search Sources API
197,761 studies31 sourcesUpdated 52 min ago
Peer-reviewedCC BY 4.0iScience

GClnc1 as an emerging oncogenic regulator with mechanistic insights and clinical implications in human cancers

  • Qing Dong
  • Yixin He
  • Rui Yu
  • Xiaochang Gong
  • Jingao Li
  • Fangteng Liu
Read full textPDFDOICite

Related

  1. Heat stroke–induced liver injury: mechanistic insights, immune dynamics, and emerging therapeutic targets
    Ning Li, Sujing Liu, Xinyu Hu +5
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyCrossref
  2. Differential Neurodevelopmental Toxicity of Propofol and Fospropofol: Mechanistic Insights and Potential Clinical Implications-A Zebrafish Model Study.
    Zhe Liu, Yingying Deng, Yuanye Gao +8
    International journal of molecular sciencesPeer-reviewedCC BYFull textNeuroscienceEurope PMC
  3. Targeting the TL1A pathway in inflammatory bowel disease: mechanistic insights and emerging therapeutic pipeline
    Mohammed Nabil Quraishi, Vipul Jairath, Badr Al-Bawardy
    Inflammatory Bowel DiseasesPeer-reviewedCC BY 4.0Full textGenetics & genomicsPMC
  4. Glutamine metabolic reprogramming in acute and chronic kidney diseases: mechanistic insights and therapeutic implications
    Ruotong Xu, Jin Zhao, Minna Liu +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossrefEurope PMC
  5. Interferon-induced transmembrane protein 3 (IFITM3) as a neuroimmune regulator in Alzheimer’s disease: emerging roles in astrocyte activation and pathological signaling
    Tianying Zhang, Jiangtao Huang, Haoping Wang +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyCrossref

Cite

BibTeXRIS
BibTeX
@article{dong2026gclnc1,
  title = {{GClnc1 as an emerging oncogenic regulator with mechanistic insights and clinical implications in human cancers}},
  author = {Qing Dong and Yixin He and Rui Yu and Xiaochang Gong and Jingao Li and Fangteng Liu},
  journal = {iScience},
  year = {2026},
  month = oct,
  doi = {10.1016/j.isci.2026.117935},
  url = {https://www.cell.com/iscience/fulltext/S2589-0042(26)03318-3},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - GClnc1 as an emerging oncogenic regulator with mechanistic insights and clinical implications in human cancers
AU  - Qing Dong
AU  - Yixin He
AU  - Rui Yu
AU  - Xiaochang Gong
AU  - Jingao Li
AU  - Fangteng Liu
PY  - 2026
DA  - 2026/10/16
JO  - iScience
DO  - 10.1016/j.isci.2026.117935
UR  - https://www.cell.com/iscience/fulltext/S2589-0042(26)03318-3
SN  - 2589-0042
ER  -